Business Context and Reporting Period
Company: IDEAYA Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 24, 2020
Reporting Period: The filing announces financial results for the three months and full year ended December 31, 2019.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
- Revenue: Not stated in filing text.
- Profit/Loss: Not stated in filing text.
- Cash Flow: Not stated in filing text.
- Debt and Liquidity: Not stated in filing text.
Material Changes
The filing text does not contain specific comparative data or descriptions of material changes versus the prior comparable period. Investors must refer to the attached press release for this information.
Guidance, Outlook, and Risks
Management Commentary: The filing confirms the announcement of 2019 financial results but does not include specific commentary, guidance, or outlook within the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt.
Unusual Items: None identified in the text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 24, 2020) for actual financial figures, as they are not included in the 8-K body text.
- Verify the company's status as an Emerging Growth Company (indicated as checked in the filing).
- Confirm the specific details of the 2019 full-year and Q4 results referenced in the announcement.